169 related articles for article (PubMed ID: 15784544)
21. Role of surfactant protein-A in nitric oxide production and mycoplasma killing in congenic C57BL/6 mice.
Hickman-Davis JM; Gibbs-Erwin J; Lindsey JR; Matalon S
Am J Respir Cell Mol Biol; 2004 Mar; 30(3):319-25. PubMed ID: 12959946
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical diagnosis of mouse hepatitis virus and mycoplasma pulmonis infection with murine antiserum.
Liang CT; Wu SC; Huang YT; Lin YC; Chang WJ; Chou JY; Liang SC; Liu CH
J Comp Pathol; 2004; 131(2-3):214-20. PubMed ID: 15276861
[TBL] [Abstract][Full Text] [Related]
23. Development of an ELISA using a recombinant P46-like lipoprotein for diagnosis of Mycoplasma pulmonis infection in rodents.
Asano A; Torigoe D; Sasaki N; Agui T
J Vet Med Sci; 2014 Mar; 76(2):151-7. PubMed ID: 24065083
[TBL] [Abstract][Full Text] [Related]
24. Mast cells protect mice from Mycoplasma pneumonia.
Xu X; Zhang D; Lyubynska N; Wolters PJ; Killeen NP; Baluk P; McDonald DM; Hawgood S; Caughey GH
Am J Respir Crit Care Med; 2006 Jan; 173(2):219-25. PubMed ID: 16210667
[TBL] [Abstract][Full Text] [Related]
25. Elongated versions of Vlp surface lipoproteins protect Mycoplasma hyorhinis escape variants from growth-inhibiting host antibodies.
Citti C; Kim MF; Wise KS
Infect Immun; 1997 May; 65(5):1773-85. PubMed ID: 9125561
[TBL] [Abstract][Full Text] [Related]
26. The Vlp system of Mycoplasma hyorhinis: combinatorial expression of distinct size variant lipoproteins generating high-frequency surface antigenic variation.
Rosengarten R; Wise KS
J Bacteriol; 1991 Aug; 173(15):4782-93. PubMed ID: 1856172
[TBL] [Abstract][Full Text] [Related]
27. Mycoplasma pulmonis V-1 surface protein variation: occurrence in vivo and association with lung lesions.
Talkington DF; Fallon MT; Watson HL; Thorp RK; Cassell GH
Microb Pathog; 1989 Dec; 7(6):429-36. PubMed ID: 2622331
[TBL] [Abstract][Full Text] [Related]
28. Activation of nuclear factor kappaB and induction of inducible nitric oxide synthase by lipid-associated membrane proteins isolated from Mycoplasma penetrans.
Zeng YH; Wu YM; Zhang WB; Yu MJ; Zhu CM; Tan LZ
Chin Med J (Engl); 2004 Jul; 117(7):997-1001. PubMed ID: 15265371
[TBL] [Abstract][Full Text] [Related]
29. Isotype commitment of B cells and dissemination of the primed state after mucosal stimulation with Mycoplasma pulmonis.
Rose FV; Cebra JJ
Infect Immun; 1985 Aug; 49(2):428-34. PubMed ID: 3874828
[TBL] [Abstract][Full Text] [Related]
30. Murine respiratory mycoplasmosis: a model to study effects of oxidants.
Davis JK; Davidson M; Schoeb TR
Res Rep Health Eff Inst; 1991 Dec; (47):1-29; discussion 31-43. PubMed ID: 1838926
[TBL] [Abstract][Full Text] [Related]
31. Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease.
Faulkner CB; Simecka JW; Davidson MK; Davis JK; Schoeb TR; Lindsey JR; Everson MP
Infect Immun; 1995 Oct; 63(10):4084-90. PubMed ID: 7558323
[TBL] [Abstract][Full Text] [Related]
32. The effect of pneumonia induced in mice with Mycoplasma pulmonis on resistance to subsequent bacterial infection and the effect of a respiratory infection with Sendai virus on the resistance of mice to Mycoplasma pulmonis.
Howard CJ; Stott EJ; Taylor G
J Gen Microbiol; 1978 Nov; 109(1):79-87. PubMed ID: 215702
[TBL] [Abstract][Full Text] [Related]
33. A family of strain-variant surface lipoproteins of Mycoplasma fermentans.
Wise KS; Kim MF; Theiss PM; Lo SC
Infect Immun; 1993 Aug; 61(8):3327-33. PubMed ID: 8335364
[TBL] [Abstract][Full Text] [Related]
34. Respiratory disease in a colony of rats. II. Isolation of Mycoplasma pulmonis from the natural disease, and the experimental disease induced with a cloned culture of this organism.
Whittlestone P; Lemcke RM; Olds RJ
J Hyg (Lond); 1972 Sep; 70(3):387-407. PubMed ID: 4506989
[TBL] [Abstract][Full Text] [Related]
35. Susceptibility to ovalbumin-induced airway inflammation and fibrosis in inducible nitric oxide synthetase-deficient mice: mechanisms and consequences.
Kenyon NJ; Gohil K; Last JA
Toxicol Appl Pharmacol; 2003 Aug; 191(1):2-11. PubMed ID: 12915099
[TBL] [Abstract][Full Text] [Related]
36. Genomic repeats, genome plasticity and the dynamics of Mycoplasma evolution.
Rocha EP; Blanchard A
Nucleic Acids Res; 2002 May; 30(9):2031-42. PubMed ID: 11972343
[TBL] [Abstract][Full Text] [Related]
37. Age-dependent increase in ischemic brain injury in wild-type mice and in mice lacking the inducible nitric oxide synthase gene.
Nagayama M; Aber T; Nagayama T; Ross ME; Iadecola C
J Cereb Blood Flow Metab; 1999 Jun; 19(6):661-6. PubMed ID: 10366196
[TBL] [Abstract][Full Text] [Related]
38. Secondary intratracheal infection of mice with Mycoplasma pulmonis generates IgG1 memory B cells.
Rose FV; Cebra JJ
Isr J Med Sci; 1987 May; 23(5):490-5. PubMed ID: 3499421
[TBL] [Abstract][Full Text] [Related]
39. Chlamydial infection in inducible nitric oxide synthase knockout mice.
Igietseme JU; Perry LL; Ananaba GA; Uriri IM; Ojior OO; Kumar SN; Caldwell HD
Infect Immun; 1998 Apr; 66(4):1282-6. PubMed ID: 9529043
[TBL] [Abstract][Full Text] [Related]
40. Role of nitric oxide in host defense in murine salmonellosis as a function of its antibacterial and antiapoptotic activities.
Alam MS; Akaike T; Okamoto S; Kubota T; Yoshitake J; Sawa T; Miyamoto Y; Tamura F; Maeda H
Infect Immun; 2002 Jun; 70(6):3130-42. PubMed ID: 12011007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
